CFO and Secretary · Mineralys Therapeutics, Inc. · Common Stock
Side
M
Value
$102K
Shares
6,613
Price
$15.44
Executed
Nov 11, 2025
Disclosed
Nov 13, 2025
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Nov 11 executedNov 13, 2025 disclosed
MLYS · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+4 / 25
$102K reported value · 5.0% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Levy Adam Scott filed this Form 4 reporting a option exercise of MLYS on Nov 11, 2025. It became public on Nov 13, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
CFO and Secretary
Levy Adam Scottcik:0001693134
Issuer
Mineralys Therapeutics, Inc.cik:0001933414
Revision history · 0
No field has changed since this record was first ingested.
